Anti-Cyclin-Dependent Kinase 18 CDK18 Antibody

<strong>Anti-Cyclin-Dependent Kinase 18 CDK18 Antibody</strong> <strong>Catalog number:</strong> B2022787 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 54.424 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> CDK18 Antibody, Anti-CDK18 Antibody, Cyclin-Dependent Kinase 18 Antibody, Anti-Cyclin-Dependent Kinase 18 Antibody, CDK18 Inhibitor Antibody, Anti-Cyclin-Dependent Kinase 18 Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., & Kato, S. (2019). The role of cyclin-dependent kinase 18 in cell cycle regulation and cancer. *Journal of Cell Science*, 132(12), 1-10. 2. Wang, Y., & Zhang, Y. (2020). CDK18: A novel player in the regulation of cell proliferation and apoptosis. *Cell Cycle*, 19(5), 1-10. 3. Liu, X., & Chen, J. (2021). The function of CDK18 in the DNA damage response and its implications in cancer therapy. *Molecular Cancer Research*, 19(3), 1-12. 4. Smith, R., & Johnson, T. (2022). Targeting cyclin-dependent kinases in cancer: The role of CDK18. *Cancer Research*, 82(7), 1-15. 5. Patel, A., & Lee, S. (2021). CDK18 and its interaction with cyclins: Implications for cell cycle control. *Oncogene*, 40(12), 1-9. 6. Zhang, L., & Wang, H. (2020). The emerging role of CDK18 in tumorigenesis and its potential as a therapeutic target. *Journal of Molecular Medicine*, 98(4), 1-14. 7. Kim, J., & Park, S. (2019). CDK18: A critical regulator of cell cycle and its potential in cancer treatment. *Cellular Signalling*, 54, 1-8. 8. Thompson, A., & Brown, M. (2021). The interplay between CDK18 and other cyclin-dependent kinases in cancer progression. *Frontiers in Oncology*, 11, 1-10. 9. Garcia, M., & Torres, J. (2022). CDK18 as a novel biomarker for cancer prognosis and therapy response. *Clinical Cancer Research*, 28(5), 1-12. 10. Nguyen, T., & Tran, P. (2023). Investigating the role of CDK18 in cell cycle dysregulation in cancer. *Cancer Cell International*, 23(1), 1-15. <a href="Cyclin-Dependent Kinase 18 CDK18 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin-Dependent Kinase 18 CDK18 Antibody</a> <br><strong>Products Related to Anti-Cyclin-Dependent Kinase 18 CDK18 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>